Introduction Faecal lactoferrin (FL) has been proposed as a non-invasive diagnostic tool in IBD.1 This is the first study conducted in a UK outpatient setting comparing simple colitis index (SCI) for ulcerative colits (UC) and Harvey Bradshaw index (HBI) for Crohn's disease (CD) against FL concentration in IBD and IBS patients.
Methods From an IBD outpatient clinic, stool samples were collected and concurrent disease activity recorded for UC, CD, IBS patients along with samples from healthy volunteers. Using IBD-Scan®, a quantitative ELISA, FL concentration was measured. Each participant's recorded clinical index at time of collection was compared against calculated FL concentration to assess clinical efficacy of FL in determining disease status in IBD and in differentiating IBD from IBS.
Results Spearman's correlation for correlation between LF and clinical score indices: 0.027 (p<0.05).
Competing interests None declared.
Reference 1. Baveye S, Elass E, Mazurier J, et al. Lactoferrin: a multifunctional glycoprotein involved in the modulation of the inflammatory process. Clin Chem Lab Med 1999;37:281–6.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.